Telehealth & Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030
The telehealth and telemdicine market is projected to reach USD 180.86 billion by 2030 from USD 94.14 billion in 2024, at a CAGR of 11.5% from 2024 to 2030. The telehealth and telemedicine market is rapidly expanding due to a variety of factors such as advancement in telecommunication technologies, government support and regulatory policies, and expansion of remote patient moniytoring systems. An aging population necessitates continuous monitoring of chronic conditions, creating a growing demand for cost-effective healthcare solutions. Furthermore, the rising prevalence of chronic diseases, such as diabetes and cardiovascular disease, emphasizes the value of remote care. Telemedicine saves a lot of time and money, hence becoming attractive for both patients and providers. The advancements in the field of telecommunications technology along with the increasing adoption of remote patient monitored technologies have enhanced the virtual care success rate and market adoption, while government support through favorable regulation and reimbursable frameworks has helped in market expansion.
“Patients segment had the fastest growth rate in the telehealth & telemedicine market during the forecast period, by end user.”
By end user, the patients segment is the fastest growing segment in the telehealth and telemedicine market during the forecast period. This is mainly due to the growing adoption of remote healthcare services, which enable patients to receive medical consultations and treatment from the comfort of their own homes. The factors that have contributed to the increase include growing chronic conditions, the need for convenient and timely medical care, and the increasing awareness of the benefits of telemedicine. The COVID-19 pandemic had also been an accelerator of telehealth, with patients seeking safer alternatives to in-person visits. Other factors that are driving this market segment include enhanced patient comfort, reduced healthcare costs, and improved access to specialists, especially in rural or underserved areas.
“By component, software segment to accounted for the largest market share in the telehealth and telemedicine market.”
Based on component, the software segment accounted for the largest market share in the telehealth and telemedicine market. This is due to the increase in the use of telehealth platforms for virtual consultation, remote patient monitoring, and electronic health record management. With use of digital resources by healthcare providers becoming widespread in delivering care in an efficient manner, software for video conferencing, appointment scheduling, secure messaging and data analytics, are fast becoming critical. The integration of artificial intelligence (AI) and machine learning in telemedicine application software also is accelerateing market expansion, providing enhanced diagnostic capabilities, tailored clinical management, and better outcomes for the patient. Moreover, the rising focus on seamless interoperability between healthcare systems and regulatory compliance for data security and privacy further accelerates the demand for advanced telehealth software.
“Asia Pacific is estimated to register the fastest CAGR over the forecast period.”
The telehealth & telemdicine market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific telehealth & telemdicine market is projected to register fastest CAGR during the forecast period. The Asia Pacific is benefiting from the fast-developing healthcare infrastructure, advances in digital technologies. It is due to multiple factors such as the rising use of digital healthcare products, healthcare needs resulting from large and ageing populations, as well as an increasing incidence of chronic diseases. Moreover, internet penetration and mobile penetration have broadened in areas such as India and China, which in turn have accelerated the growth in telehealth services. Government activities promoting telemedicine and improvements in digital health infrastructure also play a role in contributing to the growth of telehealth and telemedicine market.
Breakdown of supply-side primary interviews by company type, designation, and region:
1. Koninklijke Philips N.V. (Netherlands)
2. Medtronic (Ireland)
3. GE Healthcare (US)
4. Epic Systems Corporation (US)
5. Oracle (US)
6. Doximity, Inc. (US)
7. Teladoc Health, Inc. (US)
8. American Well (US)
9. Siemens Healthineers AG (Germany)
10. Cisco Systems Inc. (US)
11. Included Health, Inc. (Doctor on Demand, Inc.) (US)
12. AMC Health (US)
13. TeleSpecialists (US)
14. Walgreen Co. (US)
15. Caregility (US)
16. CVS Health (US)
17. EverNorth Health, Inc. (US)
18. Elation (US)
19. Iron Bow Healthcare Solutions (US)
20. ZoomCommunications, Inc. (US)
21. Timedoc Health (US)
22. Cerebral Inc. (US)
23. Kindbody (US)
24. Transcarent (US)
25. Caresimple, Inc. (US)
Research Coverage:
This research report categorizes the telehealth & telemedicine market by component (Hardware (Telehealth Kits, Carts, And Stations, Patient Monitoring Devices (Cardiac Monitoring Devices, Neurological Monitoring Devices, Respiratory Monitoring Devices, Blood Glucose Monitoring Devices, Fetal & Neonatal Monitoring Devices, Weight Monitoring Devices, Multiparameter Monitoring Devices, Pulse Oximeter Devices, Other Monitoring Devices)), Software (By Modality: EHR Centric, Non-EHR Centric, By Integration Type: Integrated Software, Standalone Software, By Type: Remote Patient Monitoring, Virtual Care Platforms (Real-Time Interaction, Store & Forward), Video Conferencing platforms, Virtual sitting & Nursing, By Deployment: On-premise model, Cloud-based model), and Services). By Function (Clinical Care Management (Including Teleconsultation & Follow-Up), Preventive Care Management, Diagnostics & Treatment, Remote Patient Monitoring/Patient Monitoring, Rehabilitation & Recovery, Administrative, Analytics & Reporting, Patient Engagement, Other Functions (Clinical Trials, Education, Training, and Others), By Application (Primary Care, Speciality Care (Teleradiology, Telecardiology, Teleneurology, Diabetes, Respiratory Disorders (COPD, Asthma, And Others), Hypertension, Teledermatology, Telestroke, Telepsychiatry (Mental Health), Others (Dental, Oncology, Obstetrics, Gynaecology, Ophthalmology, Metabolic Disorders, Immunology, Gastroenterology, Nephrology & Urology, Rare Disease, Infectious Diseases, And Others), TeleICU, Virtual Sitting & Nursing, Other Applications (Clinical Trials, Emergency & Urgent Care, General Wellness & Lifestyle Improvement, Occupational Health, and Others), By Age Group (Pediatrics, Adults, Geriatrics), By End User (Healthcare Providers (Hospitals, Ambulatory Surgical Centers, Ambulatory Care Centers, and Other Outpatient Settings, Long Term Care & Assisted Living Facilities, Home Healthcare, Other Healthcare Providers (Diagnostics & Imagining Centers, Rehabilitation Centers, Behavioural Health Centers, and Others), Healthcare Payers (Public Payers, Private Payers), Patients, Pharmaceutical & Biotechnology Companies, Medtech Companies, Other End Users (Medtech Companies, Academic Institutes, Research Centers, Government Organizations, and Others)) and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the telehealth & telemedicine market. A thorough analysis of the key industry players has been done to provide insights into their business overview, offerings, and key strategies such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals in the telehealth & telemedicine market. Competitive analysis of upcoming startups in the telehealth & telemedicine market ecosystem is covered in this report.
Reasons to Buy the Report
The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall telehealth & telemedicine market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
“Patients segment had the fastest growth rate in the telehealth & telemedicine market during the forecast period, by end user.”
By end user, the patients segment is the fastest growing segment in the telehealth and telemedicine market during the forecast period. This is mainly due to the growing adoption of remote healthcare services, which enable patients to receive medical consultations and treatment from the comfort of their own homes. The factors that have contributed to the increase include growing chronic conditions, the need for convenient and timely medical care, and the increasing awareness of the benefits of telemedicine. The COVID-19 pandemic had also been an accelerator of telehealth, with patients seeking safer alternatives to in-person visits. Other factors that are driving this market segment include enhanced patient comfort, reduced healthcare costs, and improved access to specialists, especially in rural or underserved areas.
“By component, software segment to accounted for the largest market share in the telehealth and telemedicine market.”
Based on component, the software segment accounted for the largest market share in the telehealth and telemedicine market. This is due to the increase in the use of telehealth platforms for virtual consultation, remote patient monitoring, and electronic health record management. With use of digital resources by healthcare providers becoming widespread in delivering care in an efficient manner, software for video conferencing, appointment scheduling, secure messaging and data analytics, are fast becoming critical. The integration of artificial intelligence (AI) and machine learning in telemedicine application software also is accelerateing market expansion, providing enhanced diagnostic capabilities, tailored clinical management, and better outcomes for the patient. Moreover, the rising focus on seamless interoperability between healthcare systems and regulatory compliance for data security and privacy further accelerates the demand for advanced telehealth software.
“Asia Pacific is estimated to register the fastest CAGR over the forecast period.”
The telehealth & telemdicine market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific telehealth & telemdicine market is projected to register fastest CAGR during the forecast period. The Asia Pacific is benefiting from the fast-developing healthcare infrastructure, advances in digital technologies. It is due to multiple factors such as the rising use of digital healthcare products, healthcare needs resulting from large and ageing populations, as well as an increasing incidence of chronic diseases. Moreover, internet penetration and mobile penetration have broadened in areas such as India and China, which in turn have accelerated the growth in telehealth services. Government activities promoting telemedicine and improvements in digital health infrastructure also play a role in contributing to the growth of telehealth and telemedicine market.
Breakdown of supply-side primary interviews by company type, designation, and region:
- By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
- By Designation: Managers (40%), Directors (35%), and Others (25%)
- By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%) and Middle East & Africa (2%)
1. Koninklijke Philips N.V. (Netherlands)
2. Medtronic (Ireland)
3. GE Healthcare (US)
4. Epic Systems Corporation (US)
5. Oracle (US)
6. Doximity, Inc. (US)
7. Teladoc Health, Inc. (US)
8. American Well (US)
9. Siemens Healthineers AG (Germany)
10. Cisco Systems Inc. (US)
11. Included Health, Inc. (Doctor on Demand, Inc.) (US)
12. AMC Health (US)
13. TeleSpecialists (US)
14. Walgreen Co. (US)
15. Caregility (US)
16. CVS Health (US)
17. EverNorth Health, Inc. (US)
18. Elation (US)
19. Iron Bow Healthcare Solutions (US)
20. ZoomCommunications, Inc. (US)
21. Timedoc Health (US)
22. Cerebral Inc. (US)
23. Kindbody (US)
24. Transcarent (US)
25. Caresimple, Inc. (US)
Research Coverage:
This research report categorizes the telehealth & telemedicine market by component (Hardware (Telehealth Kits, Carts, And Stations, Patient Monitoring Devices (Cardiac Monitoring Devices, Neurological Monitoring Devices, Respiratory Monitoring Devices, Blood Glucose Monitoring Devices, Fetal & Neonatal Monitoring Devices, Weight Monitoring Devices, Multiparameter Monitoring Devices, Pulse Oximeter Devices, Other Monitoring Devices)), Software (By Modality: EHR Centric, Non-EHR Centric, By Integration Type: Integrated Software, Standalone Software, By Type: Remote Patient Monitoring, Virtual Care Platforms (Real-Time Interaction, Store & Forward), Video Conferencing platforms, Virtual sitting & Nursing, By Deployment: On-premise model, Cloud-based model), and Services). By Function (Clinical Care Management (Including Teleconsultation & Follow-Up), Preventive Care Management, Diagnostics & Treatment, Remote Patient Monitoring/Patient Monitoring, Rehabilitation & Recovery, Administrative, Analytics & Reporting, Patient Engagement, Other Functions (Clinical Trials, Education, Training, and Others), By Application (Primary Care, Speciality Care (Teleradiology, Telecardiology, Teleneurology, Diabetes, Respiratory Disorders (COPD, Asthma, And Others), Hypertension, Teledermatology, Telestroke, Telepsychiatry (Mental Health), Others (Dental, Oncology, Obstetrics, Gynaecology, Ophthalmology, Metabolic Disorders, Immunology, Gastroenterology, Nephrology & Urology, Rare Disease, Infectious Diseases, And Others), TeleICU, Virtual Sitting & Nursing, Other Applications (Clinical Trials, Emergency & Urgent Care, General Wellness & Lifestyle Improvement, Occupational Health, and Others), By Age Group (Pediatrics, Adults, Geriatrics), By End User (Healthcare Providers (Hospitals, Ambulatory Surgical Centers, Ambulatory Care Centers, and Other Outpatient Settings, Long Term Care & Assisted Living Facilities, Home Healthcare, Other Healthcare Providers (Diagnostics & Imagining Centers, Rehabilitation Centers, Behavioural Health Centers, and Others), Healthcare Payers (Public Payers, Private Payers), Patients, Pharmaceutical & Biotechnology Companies, Medtech Companies, Other End Users (Medtech Companies, Academic Institutes, Research Centers, Government Organizations, and Others)) and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the telehealth & telemedicine market. A thorough analysis of the key industry players has been done to provide insights into their business overview, offerings, and key strategies such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals in the telehealth & telemedicine market. Competitive analysis of upcoming startups in the telehealth & telemedicine market ecosystem is covered in this report.
Reasons to Buy the Report
The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall telehealth & telemedicine market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers: (Growing geriatric population and increasing need to expand healthcare access, Rising prevalence of chronic conditions, Demonstrated Time and Cost Savings, Advancements in telecommunication technologies, Shortage of skilled healthcare professionals, Government support & Regulatory policies, Expansion of Remote Patient Monitoring (RPM) systems), restraints (High investment costs and lack of IT expertise, Regulatory variations across regions, Behavioral reluctance to adopt new technologies, Rise in fraud and abuse within healthcare systems, Patient privacy and confidentiality, adhering to medical ethics), opportunities (Growing use of wearables, apps, and sensors for virtual care, Emergence of AI/ML, Increasing shift towards outpatient care models, High utility of telemedicine against infectious diseases and epidemics, Expansion of hospital-at-home initiatives, Demand for EMR-based telehealth, Rapid growth of mental health care), and challenges (Data security concerns, Limited data accessibility, Inability to maintain hygiene and cleanliness standards) influencing the growth of the telehealth & telemedicine market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the telehealth & telemedicine market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the telehealth & telemedicine market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the telehealth & telemedicine market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), etc. among others in telehealth & telemedicine market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 TELEHEALTH
1.2.2 TELEMEDICINE
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & GEOGRAPHICAL SPREAD
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key sources of secondary data
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key sources of primary data
2.1.2.2 Key objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Insights from primary experts
2.2 RESEARCH APPROACH
2.3 MARKET SIZE ESTIMATION
2.3.1 REVENUE SHARE ANALYSIS (SUPPLY-SIDE ANALYSIS)
2.3.2 BOTTOM-UP APPROACH (END-USER ADOPTION)
2.3.3 TOP-DOWN APPROACH
2.3.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.4 DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 STUDY ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 TELEHEALTH & TELEMEDICINE MARKET OVERVIEW
4.2 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER AND REGION
4.3 TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT
4.4 TELEHEALTH & TELEMEDICINE MARKET: DEVELOPED VS. EMERGING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing geriatric population and increasing need for advanced healthcare infrastructure
5.2.1.2 Rising prevalence of chronic diseases
5.2.1.3 Reduced time and lower out-of-pocket costs
5.2.1.4 Advancements in telecommunication technologies
5.2.1.5 Shortage of skilled healthcare professionals
5.2.1.6 Increased government support and favorable regulatory policies
5.2.1.7 Expansion of remote patient monitoring systems
5.2.2 RESTRAINTS
5.2.2.1 High investment costs for B2B models and lack of IT expertise
5.2.2.2 State-to-state and inter-country regulatory variations
5.2.2.3 Behavioral reluctance to adopt new technologies
5.2.2.4 Rise in fraud and abuse in healthcare systems
5.2.2.5 Adherence to patient privacy, confidentiality, medical ethics
5.2.3 OPPORTUNITIES
5.2.3.1 Growing use of wearables, applications, and sensors for virtual care
5.2.3.2 Emergence of AI and ML
5.2.3.3 Increasing shift toward outpatient care models
5.2.3.4 High utility of telemedicine against infectious communicable diseases and epidemics
5.2.3.5 Expansion of hospital-at-home (HaH) initiatives
5.2.3.6 Demand for electronic medical record-based telehealth services
5.2.3.7 Rising incidence of mental illnesses and growing focus on
emotional well-being
5.2.4 CHALLENGES
5.2.4.1 Data security and confidentiality concerns
5.2.4.2 Limited data accessibility
5.2.4.3 Inability to maintain patient hygiene and cleanliness standards
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.4 INDUSTRY TRENDS
5.5 ECOSYSTEM ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Video conferencing and real-time communication platforms
5.7.1.2 AI and ML
5.7.1.3 Virtual assistants and chatbots
5.7.1.4 Voice recognition and natural language processing
5.7.1.5 EHR integration
5.7.1.6 Remote patient monitoring systems
5.7.2 COMPLEMENTARY TECHNOLOGIES
5.7.2.1 Edge computing
5.7.2.2 Cloud computing
5.7.2.3 Mobile health (mHealth) applications
5.7.2.4 Wearable devices, sensors, and IoT
5.7.3 ADJACENT TECHNOLOGIES
5.7.3.1 Digital therapeutics
5.7.3.2 Blockchain technology
5.7.3.3 Augmented reality and virtual reality
5.8 TARIFF AND REGULATORY ANALYSIS
5.8.1 TARIFF DATA ANALYSIS
5.8.1.1 Tariff data for HS code 9018
5.8.1.2 Tariff data for HS code 9021
5.8.1.3 Tariff data for HS code 9022
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.3 REGULATORY STANDARDS
5.8.4 REGULATORY FRAMEWORK
5.9 TRADE ANALYSIS
5.9.1 TRADE DATA FOR HSN CODE 90189099
5.9.1.1 Top 10 importers for HSN code 90189099
5.9.1.2 Top 10 exporters for HSN code 90189099
5.9.2 TRADE DATA FOR HSN CODE 9021
5.9.2.1 Top 10 importers for HSN code 9021
5.9.2.2 Top 10 exporters for HSN code 9021
5.9.3 TRADE DATA FOR HSN CODE 9022
5.9.3.1 Top 10 importers for HSN code 9022
5.9.3.2 Top 10 exporters for HSN code 9022
5.10 PRICING ANALYSIS
5.10.1 INDICATIVE PRICING FOR TELEHEALTH & TELEMEDICINE SOLUTIONS,
BY COMPONENT, 2023
5.10.2 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES,
BY REGION, 2023
5.10.3 PRICING MODELS
5.11 PORTER’S FIVE FORCES ANALYSIS
5.11.1 THREAT OF NEW ENTRANTS
5.11.2 THREAT OF SUBSTITUTES
5.11.3 BARGAINING POWER OF BUYERS
5.11.4 BARGAINING POWER OF SUPPLIERS
5.11.5 INTENSITY OF COMPETITIVE RIVALRY
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2 KEY BUYING CRITERIA
5.13 PATENT ANALYSIS
5.13.1 PATENT PUBLICATION TRENDS FOR TELEHEALTH & TELEMEDICINE
5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.14 UNMET NEEDS & END-USER EXPECTATIONS
5.14.1 UNMET NEEDS
5.14.2 END-USER EXPECTATIONS
5.15 KEY CONFERENCES & EVENTS, 2025–2026
5.16 CASE STUDY ANALYSIS
5.16.1 TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH TEBRA’S INTEGRATED SOLUTIONS
5.16.2 USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY ROOM TRANSFERS FROM SKILLED NURSING FACILITIES
5.16.3 CONE HEALTH TO REVOLUTIONIZE TELEHEALTH FOR TRANSITION TO CAREGILITY'S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS
5.17 INVESTMENT & FUNDING SCENARIO
5.18 BUSINESS MODEL ANALYSIS
5.18.1 DIRECT-TO-PATIENT (D2P) MODEL
5.18.2 BUSINESS-TO-BUSINESS (B2B) MODEL
5.18.3 EMPLOYER-SPONSORED MODEL
5.18.4 SUBSCRIPTION-BASED MODEL
5.18.5 HYBRID TELEMEDICINE MODEL
5.18.6 PLATFORM-AS-A-SERVICE (PAAS) MODEL
5.18.7 VALUE-BASED CARE MODEL
5.19 IMPACT OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET
5.19.1 KEY USE CASES
5.19.2 MAJOR CASE STUDIES
5.19.2.1 AI to redefine treatment effectiveness and safety
5.19.2.2 AI-driven chatbots and telehealth to enhance mental health and chronic disease management
5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
5.19.3.1 Healthcare IT and EHR systems
5.19.3.2 Pharmaceuticals & drug discovery
5.19.3.3 Mental health tech
5.19.3.4 Healthcare analytics and insights
5.19.4 USER READINESS & IMPACT ASSESSMENT
5.19.4.1 User readiness
5.19.4.1.1 User A: Hospitals
5.19.4.1.2 User B: Ambulatory surgery centers
5.19.4.2 Impact assessment
5.19.4.2.1 User A: Hospitals
5.19.4.2.2 User B: Ambulatory surgery centers
5.20 REIMBURSEMENT SCENARIO ANALYSIS
6 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT
6.1 INTRODUCTION
6.2 HARDWARE
6.2.1 TELEHEALTH KITS, CARTS, AND STATIONS
6.2.1.1 Increased focus on streamlined workflows and quality of remote healthcare services to drive adoption
6.2.2 PATIENT MONITORING DEVICES
6.2.2.1 Cardiac monitoring devices
6.2.2.1.1 Cardiac monitoring telehealth devices to minimize need for frequent hospital visits and improve patient outcomes
6.2.2.2 Neurological monitoring devices
6.2.2.2.1 Focus on better neuro care with advanced telemedicine solutions to augment segment growth
6.2.2.3 Respiratory monitoring devices
6.2.2.3.1 Rising prevalence of respiratory diseases and demand for home-based healthcare to drive segment
6.2.2.4 Blood glucose monitoring devices
6.2.2.4.1 Increasing number of diabetic patients in low- and middle-income countries to augment need for remote monitoring
6.2.2.5 Fetal & neonatal monitoring devices
6.2.2.5.1 Focus on continuous and personalized care without frequent in-person visits to drive segment
6.2.2.6 Weight monitoring devices
6.2.2.6.1 Rising prevalence of obesity and increasing awareness about weight management to drive market
6.2.2.7 Multiparameter monitoring devices
6.2.2.7.1 Rise of home healthcare and increased demand for remote patient monitoring to propel segment growth
6.2.2.8 Pulse oximeter devices
6.2.2.8.1 Remote pulse oximeter devices to manage chronic respiratory conditions and help faster patient recovery
6.2.2.9 Other patient monitoring devices
6.3 SOFTWARE
6.3.1 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY
6.3.1.1 EHR-centric software
6.3.1.1.1 EHR-centric software to improve patient information accessibility and secure sharing across platforms
6.3.1.2 Non-EHR-centric software
6.3.1.2.1 Non-EHR-centric software to conduct virtual consultations and facilitate telehealth services without constraints
6.3.2 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE
6.3.2.1 Integrated software
6.3.2.1.1 Integrated software to streamline clinical workflow and promote better access to patient health data
6.3.2.2 Standalone software
6.3.2.2.1 Increased focus on flexibility and ease of usage to fuel adoption
6.3.3 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE
6.3.3.1 Remote patient monitoring platforms
6.3.3.1.1 Increased popularity of at-home chronic disease management among geriatric patients to aid market growth
6.3.3.2 Virtual care platforms
6.3.3.2.1 Real-time interaction platforms
6.3.3.2.1.1 Synchronous nature and better healthcare access to drive segment
6.3.3.2.2 Store & forward platforms
6.3.3.2.2.1 Easy monitoring of vital signs for long-term chronic care without physical presence to fuel segment growth
6.3.3.3 Video conferencing platforms
6.3.3.3.1 Need for collaborative and coordinated care for chronic patients to augment segment growth
6.3.3.4 Virtual sitting & nursing platforms
6.3.3.4.1 Reduced workload of on-site staff and prevention of costly hospital readmissions to boost segment growth
6.3.4 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT
6.3.4.1 On-premise deployment models
6.3.4.1.1 Enhanced control and safety of inventory data with better reuse of existing infrastructure to drive market
6.3.4.2 Cloud-based deployment models
6.3.4.2.1 Need to integrate information from disparate locations in real time for database registry to drive segment
6.4 SERVICES
6.4.1 COST-EFFECTIVENESS AND REDUCED STRAIN ON HEALTHCARE PROVIDERS TO DRIVE MARKET
7 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION
7.1 INTRODUCTION
7.2 CLINICAL CARE MANAGEMENT
7.2.1 FOCUS ON REAL-TIME CONSULTATIONS, PROACTIVE MONITORING,
AND FOLLOW-UP STRATEGIES TO DRIVE MARKET
7.3 PREVENTIVE CARE MANAGEMENT
7.3.1 PREVENTIVE CARE AMONG RURAL PATIENTS TO REDUCE DELAYED DIAGNOSIS AND IMPROVE PATIENT ENGAGEMENT
7.4 DIAGNOSTICS & TREATMENT
7.4.1 DIAGNOSIS & TREATMENT TO SUPPORT PROACTIVE CARE MANAGEMENT AND DEVELOP PERSONAL HEALTHCARE PLANS
7.5 REMOTE PATIENT MONITORING/PATIENT MONITORING
7.5.1 REMOTE PATIENT MONITORING TO REVOLUTIONIZE PATIENT CARE BY IMPROVING ACCESSIBILITY, EFFICIENCY, AND HEALTH OUTCOMES
7.6 REHABILITATION & RECOVERY
7.6.1 ADOPTION OF TELEREHABILITATION TO OVERCOME REGIONAL BARRIERS AND SUPPORT PATIENTS WITH MOBILITY CHALLENGES
7.7 ADMINISTRATIVE
7.7.1 EFFICIENT ADMINISTRATIVE TASKS TO ENHANCE WORKFLOW AND IMPROVE OPERATIONAL EFFICIENCY
7.8 ANALYTICS & REPORTING
7.8.1 ADVANCED DATA ANALYTICS & REPORTING TO SUPPORT PROACTIVE DECISION-MAKING AND FOSTER BETTER CARE COORDINATION
7.9 PATIENT ENGAGEMENT
7.9.1 PROACTIVE PATIENT ENGAGEMENT TO PROMOTE ADHERENCE TO
TREATMENT PLANS AND ENABLE TIMELY INTERVENTIONS
7.10 OTHER FUNCTIONS
8 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 PRIMARY CARE
8.2.1 TECHNOLOGICAL ADVANCEMENTS AND CONVENIENT ACCESS TO HEALTHCARE FACILITIES TO AID MARKET GROWTH
8.3 SPECIALTY CARE
8.3.1 TELERADIOLOGY
8.3.1.1 Rise of cloud-based imaging solutions and AI-driven radiology tools to boost segment growth
8.3.2 TELECARDIOLOGY
8.3.2.1 Integration of AI, cloud-based ECG monitoring, and wearable health devices to fuel segment growth
8.3.3 TELENEUROLOGY
8.3.3.1 High prevalence of neurological disorders and incorporation of AI into diagnostic tools to spur segment growth
8.3.4 DIABETES
8.3.4.1 Rise in consumer demand for more accessible and cost-effective healthcare services to augment market growth
8.3.5 RESPIRATORY DISORDERS
8.3.5.1 Increasing global prevalence of chronic respiratory conditions among older adults to fuel market growth
8.3.6 HYPERTENSION
8.3.6.1 Need for continuous monitoring and rise of remote care technologies to propel market growth
8.3.7 TELEDERMATOLOGY
8.3.7.1 High prevalence of skin cancer and dermatology-related diseases to augment segment growth
8.3.8 TELESTROKE
8.3.8.1 Rising incidence of stroke and increasing geriatric population to drive market
8.3.9 TELEPSYCHIATRY
8.3.9.1 Shortage of mental health practitioners and poor access to psychiatric care in rural areas to fuel market growth
8.3.10 OTHER SPECIALTY CARE APPLICATIONS
8.4 TELEICU
8.4.1 INCREASED EMERGENCY DEPARTMENT VISITS AND UNEVEN DISTRIBUTION OF SPECIALISTS TO SUPPORT MARKET GROWTH
8.5 VIRTUAL SITTING & NURSING
8.5.1 INCREASING DEMAND FOR HOME-BASED HEALTHCARE SERVICES TO FUEL MARKET GROWTH
8.6 OTHER APPLICATIONS
9 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP
9.1 INTRODUCTION
9.2 PEDIATRICS
9.2.1 INCREASING DEMAND FOR ACCESSIBLE AND CONVENIENT HEALTHCARE FOR CHILDREN IN RURAL AREAS TO DRIVE MARKET
9.3 ADULTS
9.3.1 HIGH DEMAND FOR REMOTE ROUTINE CHECK-UPS AND CHRONIC DISEASE MANAGEMENT TO PROPEL MARKET GROWTH
9.4 GERIATRICS
9.4.1 RISING GERIATRIC POPULATION TO AUGMENT NEED FOR REMOTE MEDICAL CONSULTATIONS
10 TELEHEALTH & TELEMEDICINE MARKET, BY END USER
10.1 INTRODUCTION
10.2 HEALTHCARE PROVIDERS
10.2.1 HOSPITALS
10.2.1.1 Increasing demand for advanced and high-quality to drive market
10.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS
10.2.2.1 High preference, minimized patient downtime, and reduced hospital stay to augment segment growth
10.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES
10.2.3.1 Need for prolonged treatment for chronic diseases and preference for participatory and preventive care to drive segment
10.2.4 HOME HEALTHCARE
10.2.4.1 Rising prevalence of chronic diseases and need for cost-effective solutions to aid market growth
10.2.5 OTHER HEALTHCARE PROVIDERS
10.3 HEALTHCARE PAYERS
10.3.1 PUBLIC HEALTHCARE PAYERS
10.3.1.1 Increasing healthcare R&D investments and favorable policies to drive segment
10.3.2 PRIVATE HEALTHCARE PAYERS
10.3.2.1 Implementation of telehealth services for mental health issues and substance usage to drive segment
10.4 PATIENTS
10.4.1 RISING GERIATRIC POPULATION TO INCREASE FOCUS ON TELEHEALTH SERVICES FOR LONG-TERM CARE NEEDS
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.5.1 RISE OF VIRTUAL CONSULTATIONS AND TELEMEDICINE PLATFORMS TO INCREASE CLINICAL TRIALS WITHOUT REGIONAL BARRIERS
10.6 MEDTECH COMPANIES
10.6.1 INCREASED DEMAND FOR INNOVATIVE HEALTHCARE DEVICES FOR REMOTE DIAGNOSIS AND TREATMENT TO AID MARKET GROWTH
10.7 OTHER END USERS
11 TELEHEALTH & TELEMEDICINE MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 US to dominate North American telehealth & telemedicine market during study period
11.2.3 CANADA
11.2.3.1 Push for digital health integration to drive higher adoption of telehealth services
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 Favorable government legislation for digitalized healthcare to spur market growth
11.3.3 UK
11.3.3.1 Increased government focus on digital health solutions to aid market growth
11.3.4 FRANCE
11.3.4.1 Strategic investments and government policy reforms to fuel uptake of digital medical devices for treatment
11.3.5 ITALY
11.3.5.1 Increased government healthcare investments to foster greater efficiency and accessibility in digital health solutions
11.3.6 SPAIN
11.3.6.1 Developed eHealth sector and increased adoption of wearable health tracking devices to augment market growth
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 CHINA
11.4.2.1 Investments in digital healthcare solutions to drive market
11.4.3 JAPAN
11.4.3.1 Favorable legal revisions and advancements in video and audio communication to aid market growth
11.4.4 INDIA
11.4.4.1 Ongoing digital transformation initiatives through favorable government schemes to support market adoption
11.4.5 AUSTRALIA
11.4.5.1 Significant government investments in rural, remote, and specialist aged care services to fuel uptake
11.4.6 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Increased availability of smartphones and improved internet connectivity to propel market growth
11.5.3 MEXICO
11.5.3.1 Regulatory improvements in telemedicine consultations to boost market growth
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.6.2 GCC COUNTRIES
11.6.2.1 Shortage of healthcare workforce to drive adoption of telehealth services
11.6.3 REST OF MIDDLE EAST & AFRICA
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
TELEHEALTH & TELEMEDICINE MARKET
12.3 REVENUE ANALYSIS, 2019–2023
12.4 MARKET SHARE ANALYSIS, 2023
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Function footprint
12.5.5.4 Application footprint
12.5.5.5 Component footprint
12.5.5.6 End-user footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.6.5.1 Detailed list of key startups/SMEs
12.6.5.2 Competitive benchmarking of key startups/SMEs
12.7 COMPANY VALUATION & FINANCIAL METRICS
12.8 BRAND/SOFTWARE COMPARATIVE ANALYSIS
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES & APPROVALS
12.9.2 DEALS
12.9.3 EXPANSIONS
12.9.4 OTHER DEVELOPMENTS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 MEDTRONIC
13.1.1.1 Business overview
13.1.1.2 Products/Services/Solutions offered
13.1.1.3 Recent developments
13.1.1.3.1 Product launches & approvals
13.1.1.3.2 Deals
13.1.1.4 MnM view
13.1.1.4.1 Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 TELADOC HEALTH, INC.
13.1.2.1 Business overview
13.1.2.2 Products/Services/Solutions offered
13.1.2.3 Recent developments
13.1.2.3.1 Product launches & enhancements
13.1.2.3.2 Deals
13.1.2.4 MnM view
13.1.2.4.1 Right to win
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 CISCO SYSTEMS, INC.
13.1.3.1 Business overview
13.1.3.2 Products/Services/Solutions offered
13.1.3.3 MnM view
13.1.3.3.1 Right to win
13.1.3.3.2 Strategic choices
13.1.3.3.3 Weaknesses & competitive threats
13.1.4 KONINKLIJKE PHILIPS N.V.
13.1.4.1 Business overview
13.1.4.2 Products/Services/Solutions offered
13.1.4.3 Recent developments
13.1.4.3.1 Product launches & approvals
13.1.4.3.2 Deals
13.1.4.4 MnM view
13.1.4.4.1 Right to win
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses & competitive threats
13.1.5 ZOOM COMMUNICATIONS, INC.
13.1.5.1 Business overview
13.1.5.2 Products/Services/Solutions offered
13.1.5.3 Recent developments
13.1.5.3.1 Deals
13.1.5.4 MnM view
13.1.5.4.1 Right to win
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses & competitive threats
13.1.6 GE HEALTHCARE
13.1.6.1 Business overview
13.1.6.2 Products/Services/Solutions offered
13.1.6.3 Recent developments
13.1.6.3.1 Product launches & approvals
13.1.6.3.2 Deals
13.1.7 EPIC SYSTEMS CORPORATION
13.1.7.1 Business overview
13.1.7.2 Products/Services/Solutions offered
13.1.7.3 Recent developments
13.1.7.3.1 Product launches & enhancements
13.1.7.3.2 Deals
13.1.8 ORACLE
13.1.8.1 Business overview
13.1.8.2 Products/Services/Solutions offered
13.1.8.3 Recent developments
13.1.8.3.1 Product launches
13.1.8.3.2 Deals
13.1.9 DOXIMITY, INC.
13.1.9.1 Business overview
13.1.9.2 Products/Services/Solutions offered
13.1.9.3 Recent developments
13.1.9.3.1 Product enhancements
13.1.9.3.2 Deals
13.1.9.3.3 Other developments
13.1.10 AMERICAN WELL
13.1.10.1 Business overview
13.1.10.2 Products/Services/Solutions offered
13.1.10.3 Recent developments
13.1.10.3.1 Product launches
13.1.10.3.2 Deals
13.1.10.3.3 Other developments
13.1.11 SIEMENS HEALTHINEERS AG
13.1.11.1 Business overview
13.1.11.2 Products/Services/Solutions offered
13.1.11.3 Recent developments
13.1.11.3.1 Product launches & approvals
13.1.11.3.2 Deals
13.1.12 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.)
13.1.12.1 Business overview
13.1.12.2 Products/Services/Solutions offered
13.1.12.3 Recent developments
13.1.12.3.1 Deals
13.1.12.3.2 Other developments
13.1.13 AMC HEALTH
13.1.13.1 Business overview
13.1.13.2 Products/Services/Solutions offered
13.1.13.3 Recent developments
13.1.13.3.1 Deals
13.1.14 TELESPECIALISTS
13.1.14.1 Business overview
13.1.14.2 Products/Services/Solutions offered
13.1.14.3 Recent developments
13.1.14.3.1 Product launches
13.1.14.3.2 Deals
13.1.14.3.3 Other developments
13.1.15 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.)
13.1.15.1 Business overview
13.1.15.2 Products/Services/Solutions offered
13.1.15.3 Recent developments
13.1.15.3.1 Product launches
13.1.15.3.2 Deals
13.1.15.3.3 Expansions
13.1.16 CAREGILITY
13.1.16.1 Business overview
13.1.16.2 Products/Services/Solutions offered
13.1.16.3 Recent developments
13.1.16.3.1 Product launches
13.1.16.3.2 Deals
13.1.16.3.3 Other developments
13.1.17 CVS HEALTH
13.1.17.1 Business overview
13.1.17.2 Products/Services/Solutions offered
13.1.17.3 Recent developments
13.1.17.3.1 Product launches
13.1.17.3.2 Deals
13.1.18 EVERNORTH HEALTH, INC.
13.1.18.1 Business overview
13.1.18.2 Products/Services/Solutions offered
13.1.18.3 Recent developments
13.1.18.3.1 Deals
13.1.19 ELATION
13.1.19.1 Business overview
13.1.19.2 Products/Services/Solutions offered
13.1.19.3 Recent developments
13.1.19.3.1 Deals
13.1.20 IRON BOW TECHNOLOGIES
13.1.20.1 Business overview
13.1.20.2 Products/Services/Solutions offered
13.2 OTHER PLAYERS
13.2.1 TIMEDOC, INC.
13.2.2 CEREBRAL INC.
13.2.3 KINDBODY
13.2.4 TRANSCARENT
13.2.5 CARESIMPLE INC.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 TELEHEALTH
1.2.2 TELEMEDICINE
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & GEOGRAPHICAL SPREAD
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key sources of secondary data
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key sources of primary data
2.1.2.2 Key objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Insights from primary experts
2.2 RESEARCH APPROACH
2.3 MARKET SIZE ESTIMATION
2.3.1 REVENUE SHARE ANALYSIS (SUPPLY-SIDE ANALYSIS)
2.3.2 BOTTOM-UP APPROACH (END-USER ADOPTION)
2.3.3 TOP-DOWN APPROACH
2.3.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.4 DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 STUDY ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 TELEHEALTH & TELEMEDICINE MARKET OVERVIEW
4.2 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER AND REGION
4.3 TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT
4.4 TELEHEALTH & TELEMEDICINE MARKET: DEVELOPED VS. EMERGING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing geriatric population and increasing need for advanced healthcare infrastructure
5.2.1.2 Rising prevalence of chronic diseases
5.2.1.3 Reduced time and lower out-of-pocket costs
5.2.1.4 Advancements in telecommunication technologies
5.2.1.5 Shortage of skilled healthcare professionals
5.2.1.6 Increased government support and favorable regulatory policies
5.2.1.7 Expansion of remote patient monitoring systems
5.2.2 RESTRAINTS
5.2.2.1 High investment costs for B2B models and lack of IT expertise
5.2.2.2 State-to-state and inter-country regulatory variations
5.2.2.3 Behavioral reluctance to adopt new technologies
5.2.2.4 Rise in fraud and abuse in healthcare systems
5.2.2.5 Adherence to patient privacy, confidentiality, medical ethics
5.2.3 OPPORTUNITIES
5.2.3.1 Growing use of wearables, applications, and sensors for virtual care
5.2.3.2 Emergence of AI and ML
5.2.3.3 Increasing shift toward outpatient care models
5.2.3.4 High utility of telemedicine against infectious communicable diseases and epidemics
5.2.3.5 Expansion of hospital-at-home (HaH) initiatives
5.2.3.6 Demand for electronic medical record-based telehealth services
5.2.3.7 Rising incidence of mental illnesses and growing focus on
emotional well-being
5.2.4 CHALLENGES
5.2.4.1 Data security and confidentiality concerns
5.2.4.2 Limited data accessibility
5.2.4.3 Inability to maintain patient hygiene and cleanliness standards
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.4 INDUSTRY TRENDS
5.5 ECOSYSTEM ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Video conferencing and real-time communication platforms
5.7.1.2 AI and ML
5.7.1.3 Virtual assistants and chatbots
5.7.1.4 Voice recognition and natural language processing
5.7.1.5 EHR integration
5.7.1.6 Remote patient monitoring systems
5.7.2 COMPLEMENTARY TECHNOLOGIES
5.7.2.1 Edge computing
5.7.2.2 Cloud computing
5.7.2.3 Mobile health (mHealth) applications
5.7.2.4 Wearable devices, sensors, and IoT
5.7.3 ADJACENT TECHNOLOGIES
5.7.3.1 Digital therapeutics
5.7.3.2 Blockchain technology
5.7.3.3 Augmented reality and virtual reality
5.8 TARIFF AND REGULATORY ANALYSIS
5.8.1 TARIFF DATA ANALYSIS
5.8.1.1 Tariff data for HS code 9018
5.8.1.2 Tariff data for HS code 9021
5.8.1.3 Tariff data for HS code 9022
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.3 REGULATORY STANDARDS
5.8.4 REGULATORY FRAMEWORK
5.9 TRADE ANALYSIS
5.9.1 TRADE DATA FOR HSN CODE 90189099
5.9.1.1 Top 10 importers for HSN code 90189099
5.9.1.2 Top 10 exporters for HSN code 90189099
5.9.2 TRADE DATA FOR HSN CODE 9021
5.9.2.1 Top 10 importers for HSN code 9021
5.9.2.2 Top 10 exporters for HSN code 9021
5.9.3 TRADE DATA FOR HSN CODE 9022
5.9.3.1 Top 10 importers for HSN code 9022
5.9.3.2 Top 10 exporters for HSN code 9022
5.10 PRICING ANALYSIS
5.10.1 INDICATIVE PRICING FOR TELEHEALTH & TELEMEDICINE SOLUTIONS,
BY COMPONENT, 2023
5.10.2 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES,
BY REGION, 2023
5.10.3 PRICING MODELS
5.11 PORTER’S FIVE FORCES ANALYSIS
5.11.1 THREAT OF NEW ENTRANTS
5.11.2 THREAT OF SUBSTITUTES
5.11.3 BARGAINING POWER OF BUYERS
5.11.4 BARGAINING POWER OF SUPPLIERS
5.11.5 INTENSITY OF COMPETITIVE RIVALRY
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2 KEY BUYING CRITERIA
5.13 PATENT ANALYSIS
5.13.1 PATENT PUBLICATION TRENDS FOR TELEHEALTH & TELEMEDICINE
5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.14 UNMET NEEDS & END-USER EXPECTATIONS
5.14.1 UNMET NEEDS
5.14.2 END-USER EXPECTATIONS
5.15 KEY CONFERENCES & EVENTS, 2025–2026
5.16 CASE STUDY ANALYSIS
5.16.1 TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH TEBRA’S INTEGRATED SOLUTIONS
5.16.2 USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY ROOM TRANSFERS FROM SKILLED NURSING FACILITIES
5.16.3 CONE HEALTH TO REVOLUTIONIZE TELEHEALTH FOR TRANSITION TO CAREGILITY'S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS
5.17 INVESTMENT & FUNDING SCENARIO
5.18 BUSINESS MODEL ANALYSIS
5.18.1 DIRECT-TO-PATIENT (D2P) MODEL
5.18.2 BUSINESS-TO-BUSINESS (B2B) MODEL
5.18.3 EMPLOYER-SPONSORED MODEL
5.18.4 SUBSCRIPTION-BASED MODEL
5.18.5 HYBRID TELEMEDICINE MODEL
5.18.6 PLATFORM-AS-A-SERVICE (PAAS) MODEL
5.18.7 VALUE-BASED CARE MODEL
5.19 IMPACT OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET
5.19.1 KEY USE CASES
5.19.2 MAJOR CASE STUDIES
5.19.2.1 AI to redefine treatment effectiveness and safety
5.19.2.2 AI-driven chatbots and telehealth to enhance mental health and chronic disease management
5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
5.19.3.1 Healthcare IT and EHR systems
5.19.3.2 Pharmaceuticals & drug discovery
5.19.3.3 Mental health tech
5.19.3.4 Healthcare analytics and insights
5.19.4 USER READINESS & IMPACT ASSESSMENT
5.19.4.1 User readiness
5.19.4.1.1 User A: Hospitals
5.19.4.1.2 User B: Ambulatory surgery centers
5.19.4.2 Impact assessment
5.19.4.2.1 User A: Hospitals
5.19.4.2.2 User B: Ambulatory surgery centers
5.20 REIMBURSEMENT SCENARIO ANALYSIS
6 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT
6.1 INTRODUCTION
6.2 HARDWARE
6.2.1 TELEHEALTH KITS, CARTS, AND STATIONS
6.2.1.1 Increased focus on streamlined workflows and quality of remote healthcare services to drive adoption
6.2.2 PATIENT MONITORING DEVICES
6.2.2.1 Cardiac monitoring devices
6.2.2.1.1 Cardiac monitoring telehealth devices to minimize need for frequent hospital visits and improve patient outcomes
6.2.2.2 Neurological monitoring devices
6.2.2.2.1 Focus on better neuro care with advanced telemedicine solutions to augment segment growth
6.2.2.3 Respiratory monitoring devices
6.2.2.3.1 Rising prevalence of respiratory diseases and demand for home-based healthcare to drive segment
6.2.2.4 Blood glucose monitoring devices
6.2.2.4.1 Increasing number of diabetic patients in low- and middle-income countries to augment need for remote monitoring
6.2.2.5 Fetal & neonatal monitoring devices
6.2.2.5.1 Focus on continuous and personalized care without frequent in-person visits to drive segment
6.2.2.6 Weight monitoring devices
6.2.2.6.1 Rising prevalence of obesity and increasing awareness about weight management to drive market
6.2.2.7 Multiparameter monitoring devices
6.2.2.7.1 Rise of home healthcare and increased demand for remote patient monitoring to propel segment growth
6.2.2.8 Pulse oximeter devices
6.2.2.8.1 Remote pulse oximeter devices to manage chronic respiratory conditions and help faster patient recovery
6.2.2.9 Other patient monitoring devices
6.3 SOFTWARE
6.3.1 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY
6.3.1.1 EHR-centric software
6.3.1.1.1 EHR-centric software to improve patient information accessibility and secure sharing across platforms
6.3.1.2 Non-EHR-centric software
6.3.1.2.1 Non-EHR-centric software to conduct virtual consultations and facilitate telehealth services without constraints
6.3.2 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE
6.3.2.1 Integrated software
6.3.2.1.1 Integrated software to streamline clinical workflow and promote better access to patient health data
6.3.2.2 Standalone software
6.3.2.2.1 Increased focus on flexibility and ease of usage to fuel adoption
6.3.3 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE
6.3.3.1 Remote patient monitoring platforms
6.3.3.1.1 Increased popularity of at-home chronic disease management among geriatric patients to aid market growth
6.3.3.2 Virtual care platforms
6.3.3.2.1 Real-time interaction platforms
6.3.3.2.1.1 Synchronous nature and better healthcare access to drive segment
6.3.3.2.2 Store & forward platforms
6.3.3.2.2.1 Easy monitoring of vital signs for long-term chronic care without physical presence to fuel segment growth
6.3.3.3 Video conferencing platforms
6.3.3.3.1 Need for collaborative and coordinated care for chronic patients to augment segment growth
6.3.3.4 Virtual sitting & nursing platforms
6.3.3.4.1 Reduced workload of on-site staff and prevention of costly hospital readmissions to boost segment growth
6.3.4 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT
6.3.4.1 On-premise deployment models
6.3.4.1.1 Enhanced control and safety of inventory data with better reuse of existing infrastructure to drive market
6.3.4.2 Cloud-based deployment models
6.3.4.2.1 Need to integrate information from disparate locations in real time for database registry to drive segment
6.4 SERVICES
6.4.1 COST-EFFECTIVENESS AND REDUCED STRAIN ON HEALTHCARE PROVIDERS TO DRIVE MARKET
7 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION
7.1 INTRODUCTION
7.2 CLINICAL CARE MANAGEMENT
7.2.1 FOCUS ON REAL-TIME CONSULTATIONS, PROACTIVE MONITORING,
AND FOLLOW-UP STRATEGIES TO DRIVE MARKET
7.3 PREVENTIVE CARE MANAGEMENT
7.3.1 PREVENTIVE CARE AMONG RURAL PATIENTS TO REDUCE DELAYED DIAGNOSIS AND IMPROVE PATIENT ENGAGEMENT
7.4 DIAGNOSTICS & TREATMENT
7.4.1 DIAGNOSIS & TREATMENT TO SUPPORT PROACTIVE CARE MANAGEMENT AND DEVELOP PERSONAL HEALTHCARE PLANS
7.5 REMOTE PATIENT MONITORING/PATIENT MONITORING
7.5.1 REMOTE PATIENT MONITORING TO REVOLUTIONIZE PATIENT CARE BY IMPROVING ACCESSIBILITY, EFFICIENCY, AND HEALTH OUTCOMES
7.6 REHABILITATION & RECOVERY
7.6.1 ADOPTION OF TELEREHABILITATION TO OVERCOME REGIONAL BARRIERS AND SUPPORT PATIENTS WITH MOBILITY CHALLENGES
7.7 ADMINISTRATIVE
7.7.1 EFFICIENT ADMINISTRATIVE TASKS TO ENHANCE WORKFLOW AND IMPROVE OPERATIONAL EFFICIENCY
7.8 ANALYTICS & REPORTING
7.8.1 ADVANCED DATA ANALYTICS & REPORTING TO SUPPORT PROACTIVE DECISION-MAKING AND FOSTER BETTER CARE COORDINATION
7.9 PATIENT ENGAGEMENT
7.9.1 PROACTIVE PATIENT ENGAGEMENT TO PROMOTE ADHERENCE TO
TREATMENT PLANS AND ENABLE TIMELY INTERVENTIONS
7.10 OTHER FUNCTIONS
8 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 PRIMARY CARE
8.2.1 TECHNOLOGICAL ADVANCEMENTS AND CONVENIENT ACCESS TO HEALTHCARE FACILITIES TO AID MARKET GROWTH
8.3 SPECIALTY CARE
8.3.1 TELERADIOLOGY
8.3.1.1 Rise of cloud-based imaging solutions and AI-driven radiology tools to boost segment growth
8.3.2 TELECARDIOLOGY
8.3.2.1 Integration of AI, cloud-based ECG monitoring, and wearable health devices to fuel segment growth
8.3.3 TELENEUROLOGY
8.3.3.1 High prevalence of neurological disorders and incorporation of AI into diagnostic tools to spur segment growth
8.3.4 DIABETES
8.3.4.1 Rise in consumer demand for more accessible and cost-effective healthcare services to augment market growth
8.3.5 RESPIRATORY DISORDERS
8.3.5.1 Increasing global prevalence of chronic respiratory conditions among older adults to fuel market growth
8.3.6 HYPERTENSION
8.3.6.1 Need for continuous monitoring and rise of remote care technologies to propel market growth
8.3.7 TELEDERMATOLOGY
8.3.7.1 High prevalence of skin cancer and dermatology-related diseases to augment segment growth
8.3.8 TELESTROKE
8.3.8.1 Rising incidence of stroke and increasing geriatric population to drive market
8.3.9 TELEPSYCHIATRY
8.3.9.1 Shortage of mental health practitioners and poor access to psychiatric care in rural areas to fuel market growth
8.3.10 OTHER SPECIALTY CARE APPLICATIONS
8.4 TELEICU
8.4.1 INCREASED EMERGENCY DEPARTMENT VISITS AND UNEVEN DISTRIBUTION OF SPECIALISTS TO SUPPORT MARKET GROWTH
8.5 VIRTUAL SITTING & NURSING
8.5.1 INCREASING DEMAND FOR HOME-BASED HEALTHCARE SERVICES TO FUEL MARKET GROWTH
8.6 OTHER APPLICATIONS
9 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP
9.1 INTRODUCTION
9.2 PEDIATRICS
9.2.1 INCREASING DEMAND FOR ACCESSIBLE AND CONVENIENT HEALTHCARE FOR CHILDREN IN RURAL AREAS TO DRIVE MARKET
9.3 ADULTS
9.3.1 HIGH DEMAND FOR REMOTE ROUTINE CHECK-UPS AND CHRONIC DISEASE MANAGEMENT TO PROPEL MARKET GROWTH
9.4 GERIATRICS
9.4.1 RISING GERIATRIC POPULATION TO AUGMENT NEED FOR REMOTE MEDICAL CONSULTATIONS
10 TELEHEALTH & TELEMEDICINE MARKET, BY END USER
10.1 INTRODUCTION
10.2 HEALTHCARE PROVIDERS
10.2.1 HOSPITALS
10.2.1.1 Increasing demand for advanced and high-quality to drive market
10.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS
10.2.2.1 High preference, minimized patient downtime, and reduced hospital stay to augment segment growth
10.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES
10.2.3.1 Need for prolonged treatment for chronic diseases and preference for participatory and preventive care to drive segment
10.2.4 HOME HEALTHCARE
10.2.4.1 Rising prevalence of chronic diseases and need for cost-effective solutions to aid market growth
10.2.5 OTHER HEALTHCARE PROVIDERS
10.3 HEALTHCARE PAYERS
10.3.1 PUBLIC HEALTHCARE PAYERS
10.3.1.1 Increasing healthcare R&D investments and favorable policies to drive segment
10.3.2 PRIVATE HEALTHCARE PAYERS
10.3.2.1 Implementation of telehealth services for mental health issues and substance usage to drive segment
10.4 PATIENTS
10.4.1 RISING GERIATRIC POPULATION TO INCREASE FOCUS ON TELEHEALTH SERVICES FOR LONG-TERM CARE NEEDS
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.5.1 RISE OF VIRTUAL CONSULTATIONS AND TELEMEDICINE PLATFORMS TO INCREASE CLINICAL TRIALS WITHOUT REGIONAL BARRIERS
10.6 MEDTECH COMPANIES
10.6.1 INCREASED DEMAND FOR INNOVATIVE HEALTHCARE DEVICES FOR REMOTE DIAGNOSIS AND TREATMENT TO AID MARKET GROWTH
10.7 OTHER END USERS
11 TELEHEALTH & TELEMEDICINE MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 US to dominate North American telehealth & telemedicine market during study period
11.2.3 CANADA
11.2.3.1 Push for digital health integration to drive higher adoption of telehealth services
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 Favorable government legislation for digitalized healthcare to spur market growth
11.3.3 UK
11.3.3.1 Increased government focus on digital health solutions to aid market growth
11.3.4 FRANCE
11.3.4.1 Strategic investments and government policy reforms to fuel uptake of digital medical devices for treatment
11.3.5 ITALY
11.3.5.1 Increased government healthcare investments to foster greater efficiency and accessibility in digital health solutions
11.3.6 SPAIN
11.3.6.1 Developed eHealth sector and increased adoption of wearable health tracking devices to augment market growth
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 CHINA
11.4.2.1 Investments in digital healthcare solutions to drive market
11.4.3 JAPAN
11.4.3.1 Favorable legal revisions and advancements in video and audio communication to aid market growth
11.4.4 INDIA
11.4.4.1 Ongoing digital transformation initiatives through favorable government schemes to support market adoption
11.4.5 AUSTRALIA
11.4.5.1 Significant government investments in rural, remote, and specialist aged care services to fuel uptake
11.4.6 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Increased availability of smartphones and improved internet connectivity to propel market growth
11.5.3 MEXICO
11.5.3.1 Regulatory improvements in telemedicine consultations to boost market growth
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.6.2 GCC COUNTRIES
11.6.2.1 Shortage of healthcare workforce to drive adoption of telehealth services
11.6.3 REST OF MIDDLE EAST & AFRICA
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
TELEHEALTH & TELEMEDICINE MARKET
12.3 REVENUE ANALYSIS, 2019–2023
12.4 MARKET SHARE ANALYSIS, 2023
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Function footprint
12.5.5.4 Application footprint
12.5.5.5 Component footprint
12.5.5.6 End-user footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.6.5.1 Detailed list of key startups/SMEs
12.6.5.2 Competitive benchmarking of key startups/SMEs
12.7 COMPANY VALUATION & FINANCIAL METRICS
12.8 BRAND/SOFTWARE COMPARATIVE ANALYSIS
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES & APPROVALS
12.9.2 DEALS
12.9.3 EXPANSIONS
12.9.4 OTHER DEVELOPMENTS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 MEDTRONIC
13.1.1.1 Business overview
13.1.1.2 Products/Services/Solutions offered
13.1.1.3 Recent developments
13.1.1.3.1 Product launches & approvals
13.1.1.3.2 Deals
13.1.1.4 MnM view
13.1.1.4.1 Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 TELADOC HEALTH, INC.
13.1.2.1 Business overview
13.1.2.2 Products/Services/Solutions offered
13.1.2.3 Recent developments
13.1.2.3.1 Product launches & enhancements
13.1.2.3.2 Deals
13.1.2.4 MnM view
13.1.2.4.1 Right to win
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 CISCO SYSTEMS, INC.
13.1.3.1 Business overview
13.1.3.2 Products/Services/Solutions offered
13.1.3.3 MnM view
13.1.3.3.1 Right to win
13.1.3.3.2 Strategic choices
13.1.3.3.3 Weaknesses & competitive threats
13.1.4 KONINKLIJKE PHILIPS N.V.
13.1.4.1 Business overview
13.1.4.2 Products/Services/Solutions offered
13.1.4.3 Recent developments
13.1.4.3.1 Product launches & approvals
13.1.4.3.2 Deals
13.1.4.4 MnM view
13.1.4.4.1 Right to win
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses & competitive threats
13.1.5 ZOOM COMMUNICATIONS, INC.
13.1.5.1 Business overview
13.1.5.2 Products/Services/Solutions offered
13.1.5.3 Recent developments
13.1.5.3.1 Deals
13.1.5.4 MnM view
13.1.5.4.1 Right to win
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses & competitive threats
13.1.6 GE HEALTHCARE
13.1.6.1 Business overview
13.1.6.2 Products/Services/Solutions offered
13.1.6.3 Recent developments
13.1.6.3.1 Product launches & approvals
13.1.6.3.2 Deals
13.1.7 EPIC SYSTEMS CORPORATION
13.1.7.1 Business overview
13.1.7.2 Products/Services/Solutions offered
13.1.7.3 Recent developments
13.1.7.3.1 Product launches & enhancements
13.1.7.3.2 Deals
13.1.8 ORACLE
13.1.8.1 Business overview
13.1.8.2 Products/Services/Solutions offered
13.1.8.3 Recent developments
13.1.8.3.1 Product launches
13.1.8.3.2 Deals
13.1.9 DOXIMITY, INC.
13.1.9.1 Business overview
13.1.9.2 Products/Services/Solutions offered
13.1.9.3 Recent developments
13.1.9.3.1 Product enhancements
13.1.9.3.2 Deals
13.1.9.3.3 Other developments
13.1.10 AMERICAN WELL
13.1.10.1 Business overview
13.1.10.2 Products/Services/Solutions offered
13.1.10.3 Recent developments
13.1.10.3.1 Product launches
13.1.10.3.2 Deals
13.1.10.3.3 Other developments
13.1.11 SIEMENS HEALTHINEERS AG
13.1.11.1 Business overview
13.1.11.2 Products/Services/Solutions offered
13.1.11.3 Recent developments
13.1.11.3.1 Product launches & approvals
13.1.11.3.2 Deals
13.1.12 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.)
13.1.12.1 Business overview
13.1.12.2 Products/Services/Solutions offered
13.1.12.3 Recent developments
13.1.12.3.1 Deals
13.1.12.3.2 Other developments
13.1.13 AMC HEALTH
13.1.13.1 Business overview
13.1.13.2 Products/Services/Solutions offered
13.1.13.3 Recent developments
13.1.13.3.1 Deals
13.1.14 TELESPECIALISTS
13.1.14.1 Business overview
13.1.14.2 Products/Services/Solutions offered
13.1.14.3 Recent developments
13.1.14.3.1 Product launches
13.1.14.3.2 Deals
13.1.14.3.3 Other developments
13.1.15 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.)
13.1.15.1 Business overview
13.1.15.2 Products/Services/Solutions offered
13.1.15.3 Recent developments
13.1.15.3.1 Product launches
13.1.15.3.2 Deals
13.1.15.3.3 Expansions
13.1.16 CAREGILITY
13.1.16.1 Business overview
13.1.16.2 Products/Services/Solutions offered
13.1.16.3 Recent developments
13.1.16.3.1 Product launches
13.1.16.3.2 Deals
13.1.16.3.3 Other developments
13.1.17 CVS HEALTH
13.1.17.1 Business overview
13.1.17.2 Products/Services/Solutions offered
13.1.17.3 Recent developments
13.1.17.3.1 Product launches
13.1.17.3.2 Deals
13.1.18 EVERNORTH HEALTH, INC.
13.1.18.1 Business overview
13.1.18.2 Products/Services/Solutions offered
13.1.18.3 Recent developments
13.1.18.3.1 Deals
13.1.19 ELATION
13.1.19.1 Business overview
13.1.19.2 Products/Services/Solutions offered
13.1.19.3 Recent developments
13.1.19.3.1 Deals
13.1.20 IRON BOW TECHNOLOGIES
13.1.20.1 Business overview
13.1.20.2 Products/Services/Solutions offered
13.2 OTHER PLAYERS
13.2.1 TIMEDOC, INC.
13.2.2 CEREBRAL INC.
13.2.3 KINDBODY
13.2.4 TRANSCARENT
13.2.5 CARESIMPLE INC.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
The global Telehealth Market was valued at $2.2 Billion in 2015 and is poised to grow at a CAGR of 24.2% to reach $6.5 Billion by 2020.
Major players in the global Telehealth market are
- Cerner Corporation (U.S.)
- Honeywell Life Care Solutions (U.S.)
- McKesson Corporation (U.S.)
- Medtronic, Inc. (U.S.)
- Robert Bosch Healthcare (U.S.)
- Cisco Systems, Inc. (U.S.)
The major factors driving the growth of the telehealth solutions market are the rise in the aging and chronically ill population, the shortage of physicians in the U.S., uneven physician distribution worldwide, improvement in telecommunication infrastructure, technological advancements, rising healthcare costs, and awareness on the benefits of tele-health. However, certain barriers, such as limited reimbursement in the U.S. and legality, privacy, and security concerns worldwide, are restraining the growth of this market.
In 2015, the North American market is expected to command the largest share of the global market, followed by Europe and Asia-Pacific. Asia-Pacific is the fastest-growing region in this market. The rapidly growing healthcare industry in India, increasing number of HCIT programs, the rising prevalence of chronic diseases in Australia, and increasing funding for telehealth in Australia will drive the growth of this market in Asia.
